AAAAAA
Results: 1-25/26
Authors:
Ladetto, M
Sametti, S
Astolfi, M
Corradini, P
Ricca, I
Drandi, D
Pileri, A
Tarella, C
Citation: M. Ladetto et al., Central nervous system relapse in a patient with mantle cell lymphoma in continuous clinical and molecular remission at six years since autografting, LEUK LYMPH, 40(5-6), 2001, pp. 679-682
Authors:
Tarella, C
Cuttica, A
Caracciolo, D
Zallio, F
Ricca, I
Bergui, L
Gavarotti, P
Marinone, C
Pagano, M
Rossi, G
de Crescenzo, A
Salomone, A
Ladetto, M
Boccadoro, M
Pileri, A
Citation: C. Tarella et al., High-dose sequential (HDS) chemotherapy for high-risk non-Hodgkin's lymphoma: long-term analysis and future developments, ANN HEMATOL, 80, 2001, pp. B123-B126
Authors:
Ferrero, D
Foli, C
Giaretta, F
Argentino, C
Rus, C
Pileri, A
Citation: D. Ferrero et al., Growth advantage of chronic myeloid leukemia CFU-GM in vitro: survival to growth factor deprivation, possibly related to autocrine stimulation, is a more common feature than hypersensitivity to GM-CSF/IL3 and is efficiently counteracted by retinoids +/- alpha-interferon, LEUKEMIA, 15(3), 2001, pp. 422-429
Authors:
Tarella, C
Zallio, F
Caracciolo, D
Cuttica, A
Corradini, P
Gavarotti, P
Ladetto, M
Podio, V
Sargiotto, A
Rossi, G
Gianni, AM
Pileri, A
Citation: C. Tarella et al., High-dose mitoxantrone plus melphalan (MITO/L-PAM) as conditioning regimensupported by peripheral blood progenitor cell (PBPC) autograft in 113 lymphoma patients: high tolerability with reversible cardiotoxicity, LEUKEMIA, 15(2), 2001, pp. 256-263
Authors:
Palumbo, A
Giaccone, L
Bertola, A
Pregno, P
Bringhen, S
Rus, C
Triolo, S
Gallo, E
Pileri, A
Boccadoro, M
Citation: A. Palumbo et al., Low-dose thalidomide plus dexamethasone is an effective salvage therapy for advanced myeloma, HAEMATOLOG, 86(4), 2001, pp. 399-403
Authors:
Ladetto, M
Sametti, S
Donovan, JW
Ferrero, D
Astolfi, M
Mitterer, M
Ricca, I
Drandi, D
Corradini, P
Coser, P
Pileri, A
Gribben, JC
Tarella, C
Citation: M. Ladetto et al., A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patients, EXP HEMATOL, 29(2), 2001, pp. 183-193
Authors:
Mariani, S
Coscia, M
Even, J
Peola, S
Foglietta, M
Boccadoro, M
Sbaiz, L
Restagno, G
Pileri, A
Massaia, H
Citation: S. Mariani et al., Severe and long-lasting disruption of T-cell receptor diversity in human myeloma after high-dose chemotherapy and autologous peripheral blood progenitor cell infusion, BR J HAEM, 113(4), 2001, pp. 1051-1059
Authors:
Ladetto, M
Bergui, L
Ricca, I
Campana, S
Pileri, A
Tarella, C
Citation: M. Ladetto et al., Rituximab anti-CD20 monoclonal antibody induces marked but transient reductions of peripheral blood lymphocytes in chronic lymphocytic leukaemia patients, MED ONCOL, 17(3), 2000, pp. 203-210
Authors:
Tarella, C
Caracciolo, D
Corradini, P
Zallio, F
Ladetto, M
Cuttica, A
Rossi, G
Novero, D
Gavarotti, P
Pileri, A
Citation: C. Tarella et al., Long-term follow-up of advanced-stage low-grade lymphoma patients treated upfront with high-dose sequential chemotherapy and autograft, LEUKEMIA, 14(4), 2000, pp. 740-747
Authors:
Piccaluga, PP
Ascani, S
Orcioni, GF
Piccioli, M
Pileri, A
Falini, B
Pileri, SA
Citation: Pp. Piccaluga et al., Anaplastic lymphoma kinase expression as a marker of malignancy Application to a case of anaplastic large cell lymphoma with huge granulomatous reaction, HAEMATOLOG, 85(9), 2000, pp. 978-981
Authors:
Palumbo, A
Triolo, S
Baldini, L
Callea, V
Capaldi, A
De Stefano, V
Grasso, M
Liberati, M
Lotesoriere, C
Marceno, R
Marmont, F
Musto, P
Petrucci, MT
Spriano, M
Pileri, A
Boccadoro, M
Citation: A. Palumbo et al., Dose-intensive melphalan with stem cell support (CM regimen) is effective and well tolerated in elderly myeloma patients, HAEMATOLOG, 85(5), 2000, pp. 508-513
Authors:
Tarella, C
Caracciolo, D
Gavarotti, P
Argentino, C
Zallio, F
Corradini, P
Novero, D
Magnani, C
Pileri, A
Citation: C. Tarella et al., Overweight as an adverse prognostic factor for non-Hodgkin's lymphoma patients receiving high-dose chemotherapy and autograft, BONE MAR TR, 26(11), 2000, pp. 1185-1191
Authors:
Boccadoro, M
Omede, P
Dominietto, A
Palumbo, A
Bringhen, S
Giaretta, F
Ortolano, B
Triolo, S
Pileri, A
Citation: M. Boccadoro et al., Multiple myeloma: the number of reinfused plasma cells does not influence outcome of patients treated with intensified chemotherapy and PBPC support, BONE MAR TR, 25(1), 2000, pp. 25-29
Authors:
Besostri, B
Beggiato, E
Bianchi, A
Mariani, S
Coscia, M
Peola, S
Foglietta, M
Boccadoro, M
Pileri, A
Moretta, L
Massaia, M
Citation: B. Besostri et al., Increased expression of non-functional killer inhibitory receptor CD94 in CD8(+) cells of myeloma patients, BR J HAEM, 109(1), 2000, pp. 46-53
Authors:
Magni, M
Di Nicola, M
Devizzi, L
Matteucci, P
Lombardi, F
Gandola, L
Ravagnani, F
Giardini, R
Dastoli, G
Tarella, C
Pileri, A
Bonadonna, G
Gianni, AM
Citation: M. Magni et al., Successful in vivo purging of CD34-containing peripheral blood harvests inmantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion, BLOOD, 96(3), 2000, pp. 864-869
Authors:
Tarella, C
Zallio, F
Caracciolo, D
Cherasco, C
Bondesan, P
Gavarotti, P
Corradini, P
Tassi, V
Pileri, A
Citation: C. Tarella et al., Hemopoietic progenitor cell mobilization and harvest following an intensive chemotherapy debulking in indolent lymphoma patients, STEM CELLS, 17(1), 1999, pp. 55-61
Authors:
Bazzan, M
Tamponi, G
Schinco, P
Vaccarino, A
Foli, C
Gallone, G
Pileri, A
Citation: M. Bazzan et al., Thrombosis-free survival and life expectancy in 187 consecutive patients with essential thrombocythemia, ANN HEMATOL, 78(12), 1999, pp. 539-543
Authors:
Tarella, C
Corradini, P
Astolfi, M
Bondesan, P
Caracciolo, D
Cherasco, C
Ladetto, M
Giaretta, F
Ricca, I
Vitolo, U
Pileri, A
Ferrero, D
Citation: C. Tarella et al., Negative immunomagnetic ex vivo purging combined with high-dose chemotherapy with peripheral blood progenitor cell autograft in follicular lymphoma patients: evidence for long-term clinical and molecular remissions, LEUKEMIA, 13(9), 1999, pp. 1456-1462
Authors:
Corradini, P
Ladetto, M
Pileri, A
Tarella, C
Citation: P. Corradini et al., Clinical relevance of minimal residual disease monitoring in non-Hodgkin'slymphomas: a critical reappraisal of molecular strategies, LEUKEMIA, 13(11), 1999, pp. 1691-1695
Authors:
Corradini, P
Voena, C
Tarella, C
Astolfi, M
Ladetto, M
Palumbo, A
Van Lint, MT
Bacigalupo, A
Santoro, A
Musso, M
Majolino, I
Boccadoro, M
Pileri, A
Citation: P. Corradini et al., Molecular and clinical remissions in multiple myeloma: Role of autologous and allogeneic transplantation of hematopoietic cells, J CL ONCOL, 17(1), 1999, pp. 208-215
Authors:
Boccadoro, M
Tarella, C
Palumbo, A
Argentino, C
Triolo, S
Dominietto, A
Callea, V
Lauta, VM
Molica, S
Musto, P
Marmont, F
Gianni, AM
Pileri, A
Citation: M. Boccadoro et al., An analysis of which subgroups of multiple myeloma patients, divided according to beta(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapy, HAEMATOLOG, 84(10), 1999, pp. 905-910
Authors:
Ciaiolo, C
Ferrero, D
Pugliese, A
Ortolano, B
Borrione, P
Pileri, A
Citation: C. Ciaiolo et al., Modulation of in vitro chemosensitivity in acute myelogenous leukemia cellline by GM-CSF: opposing effects observed with different cytotoxic drugs and time exposure, LEUK RES, 23(10), 1999, pp. 931-938
Authors:
Borrione, P
Peola, S
Mariani, S
Besostri, B
Mallone, R
Malavasi, F
Pileri, A
Massaia, M
Citation: P. Borrione et al., CD38 stimulation lowers the activation threshold and enhances the alloreactivity of cord blood T cells by activating the phosphatidylinositol 3-kinase pathway and inducing CD73 expression, J IMMUNOL, 162(10), 1999, pp. 6238-6246
Authors:
Palumbo, A
Triolo, S
Argentino, C
Bringhen, S
Dominietto, A
Rus, C
Omede, P
Tarella, C
Pileri, A
Boccadoro, M
Citation: A. Palumbo et al., Dose-intensive melphalan with stem cell support (MEL100) is superior to standard treatment in elderly myeloma patients, BLOOD, 94(4), 1999, pp. 1248-1253
Authors:
Massaia, M
Borrione, P
Battaglio, S
Mariani, S
Beggiato, E
Napoli, P
Voena, C
Bianchi, A
Coscia, M
Besostri, B
Peola, S
Stiefel, T
Even, J
Novero, D
Boccadoro, M
Pileri, A
Citation: M. Massaia et al., Idiotype vaccination in human myeloma: Generation of tumor-specific immuneresponses after high-dose chemotherapy, BLOOD, 94(2), 1999, pp. 673-683